Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension

The review is devoted to the perspectives of combined therapy with verapamil SR and trandolapril in high-risk patients with arterial hypertension (AH). The results of international clinical trials confirm effectiveness of verapamil SR and trandolapril (Tarka medication) in AH combined with coronary...

Full description

Saved in:
Bibliographic Details
Main Authors: N. M. Chikhladze, I. E. Chazova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1605
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250405362434048
author N. M. Chikhladze
I. E. Chazova
author_facet N. M. Chikhladze
I. E. Chazova
author_sort N. M. Chikhladze
collection DOAJ
description The review is devoted to the perspectives of combined therapy with verapamil SR and trandolapril in high-risk patients with arterial hypertension (AH). The results of international clinical trials confirm effectiveness of verapamil SR and trandolapril (Tarka medication) in AH combined with coronary heart disease, diabetes mellitus, chronic diabetic and non-diabetic kidney diseases.
format Article
id doaj-art-be0a089893e4479ab0e95b16d5e479cc
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 1970-01-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-be0a089893e4479ab0e95b16d5e479cc2025-08-20T03:57:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-0168991051322Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertensionN. M. Chikhladze0I. E. Chazova1A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, Federal Agency on High Medical Technologies, MoscowA.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex, Federal Agency on High Medical Technologies, MoscowThe review is devoted to the perspectives of combined therapy with verapamil SR and trandolapril in high-risk patients with arterial hypertension (AH). The results of international clinical trials confirm effectiveness of verapamil SR and trandolapril (Tarka medication) in AH combined with coronary heart disease, diabetes mellitus, chronic diabetic and non-diabetic kidney diseases.https://cardiovascular.elpub.ru/jour/article/view/1605arterial hypertensionverapamil srtrandolapriltarkaorgano-protection
spellingShingle N. M. Chikhladze
I. E. Chazova
Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
Кардиоваскулярная терапия и профилактика
arterial hypertension
verapamil sr
trandolapril
tarka
organo-protection
title Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
title_full Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
title_fullStr Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
title_full_unstemmed Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
title_short Combination of verapamil and trandolapril: therapeutic potential for high-risk patients with arterial hypertension
title_sort combination of verapamil and trandolapril therapeutic potential for high risk patients with arterial hypertension
topic arterial hypertension
verapamil sr
trandolapril
tarka
organo-protection
url https://cardiovascular.elpub.ru/jour/article/view/1605
work_keys_str_mv AT nmchikhladze combinationofverapamilandtrandolapriltherapeuticpotentialforhighriskpatientswitharterialhypertension
AT iechazova combinationofverapamilandtrandolapriltherapeuticpotentialforhighriskpatientswitharterialhypertension